Relationship Between Metformin Use and Recurrence and Survival in Patients With Resected Stage III Colon Cancer Receiving Adjuvant Chemotherapy: Results From North Central Cancer Treatment Group N0147 (Alliance)
      QxMD      Google Scholar   
Citation:
Oncologist vol 21 (12) 1509-1521
Year:
2016
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
6
Parents:
2291  
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U10 CA180835, UG1 CA189974, U10 CA180821, U10 CA180847, U10 CA180850, UG1 CA189863, P30 CA015083, U10 CA180882, P30 CA016058, U10 CA180820, U10 CA076001, U10 CA180833, U10 CA180867, U10 CA025224, U10 CA180888  
Corr. Author:
 
Authors:
                           
Networks:
HEARTLAND, LAPS-MN026, LAPS-OH007, MCRC   
Study
NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
Colon cancer, Recurrence, Survival, Metformin, Diabetes mellitus, Adjuvant chemotherapy